Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

H. Lim, Sean; Stuart, Beth; Joseph‐Pietras, Débora; Johnson, Marina; Campbell, Nicola; G. Kelly, Adam; Lifson Jeffrey, D.; H. Turaj, Anna; Rolfvondenbaumen, Kate; Galloway, Celine; A. Wynn, Thomas; Coleman, Adam; Ward, Benjamin; Long, Karen; G. Coleman, Helen; Mundy, Carina; Bates, Andrew; Ayres, Diana; Lown, Robert; Falconer, J.; Brake, Oliver; Batchelor, James; Willimott, Victoria; Bowzyk Al-Naeeb, Anna; A. Robinson, Lisa; O’Callaghan, Ann; P. Collins, Graham; Menne, Tobias; N. Faust, Saul; P. Fox, Christopher; J. Ahearne, Matthew; Johnson, Peter; Davies, Andrew; Goldblatt, David

doi:10.1038/s43018-022-00364-3

Public

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Published in Nature Cancer • Mar 24, 2022

Authors:

Sean H. Lim

Beth Stuart

Débora Joseph‐Pietras

Abstract

Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitations in study design. Here we present the PROSECO prospective observational study ( NCT04858...

Subject

Medicine

Immune system

Vaccination

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!